FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155054198> ?p ?o ?g. }

• W2155054198 endingPage "1461" @default.
• W2155054198 startingPage "1454" @default.
• W2155054198 abstract "Studies in oncology have implicated multiple molecular mechanisms as contributors to intrinsic and acquired tumor resistance to antifolate therapy. Here we show the utility of an (19)F-labeled methotrexate (FMTX) with (19)F magnetic resonance to differentiate between sensitive and resistant tumors in vivo and thus predict therapeutic response.Human sarcoma xenografts in nude mice were used in this study. The sarcoma cell lines chosen for this study (HT-1080, HS-16, and M-805) are well characterized in terms of their methotrexate sensitivity and molecular mechanisms of resistance. The pharmacokinetics of tumor uptake/washout of FMTX were monitored via in vivo (19)F magnetic resonance spectroscopy (pulse/acquire with surface coil localization) following an i.v. bolus injection. Response post-therapy, following leucovorin rescue, was monitored via tumor growth.The three tumor models show differences in both the peak concentrations of tumor FMTX and the dynamics of uptake/retention. These differences are most pronounced for time points late in the magnetic resonance observation period (225-279 minutes post-injection). A statistically significant linear correlation between tumor tissue concentrations of FMTX at these late time points and therapeutic response in the days/weeks post-treatment is shown (R = 0.81, F = 9.27, P < 0.001). Interestingly, a 400 mg/kg i.v. bolus injection of FMTX is a more potent cytotoxic agent in vivo against methotrexate-sensitive tumors than is the parent compound (P = 0.011).In principle, the assay method described herein could be implemented in the clinic as a diagnostic tool to make decisions regarding therapeutic protocol for the treatment of osteosarcoma on a case-by-case basis." @default.
• W2155054198 created "2016-06-24" @default.
• W2155054198 creator A5006868141 @default.
• W2155054198 creator A5032352871 @default.
• W2155054198 creator A5032743242 @default.
• W2155054198 creator A5036062833 @default.
• W2155054198 creator A5055132064 @default.
• W2155054198 creator A5071888093 @default.
• W2155054198 creator A5083853907 @default.
• W2155054198 date "2005-02-15" @default.
• W2155054198 modified "2023-10-16" @default.
• W2155054198 title "An 19F Magnetic Resonance–Based <i>In Vivo</i> Assay of Solid Tumor Methotrexate Resistance: Proof of Principle" @default.
• W2155054198 cites W1828199879 @default.
• W2155054198 cites W1973427992 @default.
• W2155054198 cites W1975876783 @default.
• W2155054198 cites W1976334261 @default.
• W2155054198 cites W1980643299 @default.
• W2155054198 cites W1999029051 @default.
• W2155054198 cites W2011947350 @default.
• W2155054198 cites W2020326611 @default.
• W2155054198 cites W2043804660 @default.
• W2155054198 cites W2051319941 @default.
• W2155054198 cites W2052672791 @default.
• W2155054198 cites W2053723948 @default.
• W2155054198 cites W2054073458 @default.
• W2155054198 cites W2059089815 @default.
• W2155054198 cites W2061496400 @default.
• W2155054198 cites W2063440607 @default.
• W2155054198 cites W2075437346 @default.
• W2155054198 cites W2076326678 @default.
• W2155054198 cites W2080182040 @default.
• W2155054198 cites W2080727494 @default.
• W2155054198 cites W2084619794 @default.
• W2155054198 cites W2089703564 @default.
• W2155054198 cites W2091183687 @default.
• W2155054198 cites W2095340243 @default.
• W2155054198 cites W2144778685 @default.
• W2155054198 cites W2151117384 @default.
• W2155054198 cites W27270646 @default.
• W2155054198 cites W4256015233 @default.
• W2155054198 doi "https://doi.org/10.1158/1078-0432.ccr-04-1439" @default.
• W2155054198 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15746046" @default.
• W2155054198 hasPublicationYear "2005" @default.
• W2155054198 type Work @default.
• W2155054198 sameAs 2155054198 @default.
• W2155054198 citedByCount "4" @default.
• W2155054198 countsByYear W21550541982012 @default.
• W2155054198 crossrefType "journal-article" @default.
• W2155054198 hasAuthorship W2155054198A5006868141 @default.
• W2155054198 hasAuthorship W2155054198A5032352871 @default.
• W2155054198 hasAuthorship W2155054198A5032743242 @default.
• W2155054198 hasAuthorship W2155054198A5036062833 @default.
• W2155054198 hasAuthorship W2155054198A5055132064 @default.
• W2155054198 hasAuthorship W2155054198A5071888093 @default.
• W2155054198 hasAuthorship W2155054198A5083853907 @default.
• W2155054198 hasBestOaLocation W21550541981 @default.
• W2155054198 hasConcept C112705442 @default.
• W2155054198 hasConcept C121332964 @default.
• W2155054198 hasConcept C126322002 @default.
• W2155054198 hasConcept C126838900 @default.
• W2155054198 hasConcept C142724271 @default.
• W2155054198 hasConcept C143409427 @default.
• W2155054198 hasConcept C150903083 @default.
• W2155054198 hasConcept C185592680 @default.
• W2155054198 hasConcept C207001950 @default.
• W2155054198 hasConcept C2776694085 @default.
• W2155054198 hasConcept C2778256501 @default.
• W2155054198 hasConcept C2778397455 @default.
• W2155054198 hasConcept C2781059491 @default.
• W2155054198 hasConcept C2781382166 @default.
• W2155054198 hasConcept C43376680 @default.
• W2155054198 hasConcept C46141821 @default.
• W2155054198 hasConcept C502942594 @default.
• W2155054198 hasConcept C71924100 @default.
• W2155054198 hasConcept C86803240 @default.
• W2155054198 hasConcept C98274493 @default.
• W2155054198 hasConceptScore W2155054198C112705442 @default.
• W2155054198 hasConceptScore W2155054198C121332964 @default.
• W2155054198 hasConceptScore W2155054198C126322002 @default.
• W2155054198 hasConceptScore W2155054198C126838900 @default.
• W2155054198 hasConceptScore W2155054198C142724271 @default.
• W2155054198 hasConceptScore W2155054198C143409427 @default.
• W2155054198 hasConceptScore W2155054198C150903083 @default.
• W2155054198 hasConceptScore W2155054198C185592680 @default.
• W2155054198 hasConceptScore W2155054198C207001950 @default.
• W2155054198 hasConceptScore W2155054198C2776694085 @default.
• W2155054198 hasConceptScore W2155054198C2778256501 @default.
• W2155054198 hasConceptScore W2155054198C2778397455 @default.
• W2155054198 hasConceptScore W2155054198C2781059491 @default.
• W2155054198 hasConceptScore W2155054198C2781382166 @default.
• W2155054198 hasConceptScore W2155054198C43376680 @default.
• W2155054198 hasConceptScore W2155054198C46141821 @default.
• W2155054198 hasConceptScore W2155054198C502942594 @default.
• W2155054198 hasConceptScore W2155054198C71924100 @default.
• W2155054198 hasConceptScore W2155054198C86803240 @default.
• W2155054198 hasConceptScore W2155054198C98274493 @default.
• W2155054198 hasIssue "4" @default.
• W2155054198 hasLocation W21550541981 @default.

• next